Brief: Kane Biotech Signs Worldwide License Agreement With Montreal-Based I-MED Pharma
25/06/2024 14:15
June 25 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH SIGNS WORLDWIDE LICENSE AGREEMENT WITH
MONTREAL-BASED I-MED PHARMA INC.
* KANE BIOTECH LICENSES DISPERSINB TO I-MED PHARMA
* KANE BIOTECH AGREEMENT INCLUDES MINIMUM ANNUAL ROYALTIES
* KANE BIOTECH INC: LICENSE AGREEMENT COVERS A PERIOD OF
FIVE
YEARS
Source text for Eikon: ID:nGNX757d8R
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update